DK564088D0 - Nukleosidderivater - Google Patents

Nukleosidderivater

Info

Publication number
DK564088D0
DK564088D0 DK564088A DK564088A DK564088D0 DK 564088 D0 DK564088 D0 DK 564088D0 DK 564088 A DK564088 A DK 564088A DK 564088 A DK564088 A DK 564088A DK 564088 D0 DK564088 D0 DK 564088D0
Authority
DK
Denmark
Prior art keywords
nucleoside
Prior art date
Application number
DK564088A
Other languages
English (en)
Other versions
DK564088A (da
Inventor
Steve Tam
John Joseph Partridge
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK564088D0 publication Critical patent/DK564088D0/da
Publication of DK564088A publication Critical patent/DK564088A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK564088A 1987-10-09 1988-10-07 Nukleosidderivater DK564088A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10722187A 1987-10-09 1987-10-09

Publications (2)

Publication Number Publication Date
DK564088D0 true DK564088D0 (da) 1988-10-07
DK564088A DK564088A (da) 1989-04-10

Family

ID=22315505

Family Applications (1)

Application Number Title Priority Date Filing Date
DK564088A DK564088A (da) 1987-10-09 1988-10-07 Nukleosidderivater

Country Status (14)

Country Link
EP (1) EP0311100A3 (da)
JP (1) JPH01132597A (da)
KR (1) KR890006624A (da)
AU (1) AU2355488A (da)
DK (1) DK564088A (da)
FI (1) FI884627A (da)
HU (1) HU201090B (da)
IL (1) IL87949A0 (da)
MC (1) MC1982A1 (da)
NO (1) NO884497L (da)
NZ (1) NZ226481A (da)
PT (1) PT88716B (da)
YU (1) YU187788A (da)
ZA (1) ZA886890B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6448392B1 (en) 1985-03-06 2002-09-10 Chimerix, Inc. Lipid derivatives of antiviral nucleosides: liposomal incorporation and method of use
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
NZ223910A (en) * 1987-03-20 1991-02-26 Bristol Myers Co 2',3'-dideoxynucleosides, process for their production and intermediates therefor
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
US5817638A (en) * 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
GB8823320D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds
AU636678B2 (en) * 1989-11-06 1993-05-06 Nycomed Imaging As Nucleoside derivatives
US5192764A (en) * 1991-05-30 1993-03-09 Research Foundation Of State Of N.Y. Pyrazinone n-oxide nucleosides and analogs thereof
CA2079413C (en) * 1991-09-30 2003-09-09 Masakatsu Kaneko Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
CA2311581A1 (en) * 1997-11-25 1999-06-03 Protarga, Inc. Nucleoside analog compositions and uses thereof
ATE556706T1 (de) 2001-03-23 2012-05-15 Luitpold Pharm Inc Fettalkohol-arzneimittel-konjugate
JP2005500988A (ja) 2001-03-23 2005-01-13 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド 脂肪族アミン薬物複合体
WO2003063771A2 (en) * 2001-12-14 2003-08-07 Pharmasset Ltd. N4-acylcytosine nucleosides for treatment of viral iinfections
US9326983B2 (en) 2013-08-01 2016-05-03 University Of Kentucky Research Foundation Compositions and methods for treating retinal degradation
EP3261644B1 (en) * 2015-02-26 2021-06-02 University Of Kentucky Research Foundation Compositions and methods for treating retinal degradation
US11219623B2 (en) 2015-02-26 2022-01-11 University Of Kentucky Research Foundation Inflammasome inhibition for the treatment of Parkinson's disease, Alzheimer's disease and multiple sclerosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5943550B2 (ja) * 1975-08-29 1984-10-23 田辺製薬株式会社 不飽和ヌクレオシドの製法
DE3689976T2 (de) * 1985-05-15 1995-03-16 Wellcome Found Therapeutische Nucleoside und deren Herstellung.
DE3850571T2 (de) * 1987-03-24 1994-10-27 Nycomed Imaging As 2',3'-dideoxyribofuranoxid-derivate.
EP0294113A1 (en) * 1987-05-29 1988-12-07 The Wellcome Foundation Limited Therapeutic nucleosides
US4837311A (en) * 1987-06-22 1989-06-06 Hoffman-La Roche Inc. Anti-retroviral compounds

Also Published As

Publication number Publication date
AU2355488A (en) 1989-04-13
MC1982A1 (fr) 1989-11-23
FI884627A0 (fi) 1988-10-07
DK564088A (da) 1989-04-10
EP0311100A3 (de) 1990-10-31
HUT47592A (en) 1989-03-28
KR890006624A (ko) 1989-06-14
PT88716B (pt) 1992-12-31
FI884627A (fi) 1989-04-10
ZA886890B (en) 1989-05-30
NO884497L (no) 1989-04-10
JPH01132597A (ja) 1989-05-25
NZ226481A (en) 1992-01-29
NO884497D0 (no) 1988-10-07
YU187788A (en) 1990-04-30
HU201090B (en) 1990-09-28
IL87949A0 (en) 1989-03-31
EP0311100A2 (de) 1989-04-12

Similar Documents

Publication Publication Date Title
DK713488A (da) Adenosinderivater
NO2001013I2 (no) Kapecitabin
ATE138660T1 (de) Therapeutische nukleoside
ATA30988A (de) Alpinski
DK23489A (da) Nucleosidderivater
DK191688D0 (da) Terapeutiske nucleosider
ATA174488A (de) Alpinski
DK564088D0 (da) Nukleosidderivater
ATA174288A (de) Alpinski
ATA224788A (de) Calcitoninsuppositorien
DK626989D0 (da) Adenosinderivater
DK140588A (da) Terapeutisk nucleosider
KR890700914A (ko) 멀티콘덴서 배열
AT389045B (de) Paraocclusaler loeffel
ATA48687A (de) Guellefass
ATA294988A (de) Haecksler
ATA282287A (de) Antivirale 8-phenylxanthine
AT388649B (de) Sportschuh
ATA162787A (de) Hoergeraet
DK725088D0 (da) Terapeutiske nucleosider
BR6700856U (pt) Micro-semeador
BR6701645U (pt) Prendedor-cabide
BR6701063U (pt) Cesta-cofre
BR6700994U (pt) Isqueiro-cinzeiro
ATA257287A (de) Glykopeptidantibiotika

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment